Tag Archives: challenge’

BMS deal quest gets a boost as Celgene swats aside another Revlimid patent challenge

Much of the investor doubt surrounding Bristol-Myers Squibb’s $ 74 billion Celgene buyout centers on the multiple myeloma blockbuster Revlimid—namely, whether its remaining patents can stand up to legal challenges. But the companies just scored a win in that department. Thursday, the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) decided not… Read More »

2018 Winter Waistline Challenge Begins

Tuesday, November 27, 2018 The holidays…decorations, family, friends, cheer, and relaxation as we near the end of the year.  Oh, and probably feeling a bit sluggish from high sugar/alcohol intake, stress, lack of exercise and subsequent weight gain. What if we embraced all that’s great about the holidays and just left the rest. Wouldn’t it… Read More »